Global leader in medication safety, currently president of the International Society of Pharmacovigilance (ISoP), an institution with presence in 100 countries, whose mission is to improve the medication safety worldly.
Pharmacist, Epidemiologist, Ms Pharmaceutical Care, MSc Education. With 20 years of experience, she is an international consultant and lecturer in pharmacovigilance, safe use of medications and medical devices, patient safety, patient education, leadership and communication. Member of Research Ethics Committees, she was president of the Colombian Pharmacovigilance Association for 5 years, founding member and Co-chair of the ISoP Special Interest Group (SIG) “Medication errors”. ISoP SIG Risk Communication and SIG Patient Engagement member. Founding member of Latin American Network of Human Factors and Ergonomics in Healthcare Systems (RELAESA). Currently Pharmacy Career Director in Pontificia Universidad Javeriana.
Dr Grace Wangge is a medical doctor and epidemiologist, teaching in the field of Public Health and Public Health Policy. She got her medical degree from Universitas Indonesia, Indonesia and PhD from Utrecht Universiteit in the Netherlands in the field of Pharmacoepidemiology. She also had a postdoctoral fellowship with Harvard Medical School/Brigham and Women’s Hospital, Boston, USA.
Since returning to Indonesia in 2014, she has developed research expertise in community medicine, community nutrition, public health policy and pharmacovigilance. She also has years of experience in research and capacity building at the grassroots level, as well as evaluating the implementation of health and nutrition programs in primary health services in Indonesia.
A/Prof Geraldine Moses AM is a Doctor of Clinical Pharmacy specialised in Medicines Information. She works part-time in the Medicines Information Service at the Mater Hospital in Brisbane, but her main job is as consultant pharmacist to the Australian Dental Association, for whom she provides a national drug information service, writes regular articles, and presents education and podcasts. Geraldine also holds the position of Adjunct Associate Professor in the Schools of Pharmacy at the University of Queensland, QUT and the Dental School at UWA. She also consults to organisations such as the Department of Veterans Affairs, the Commission for Safety and Quality in Healthcare and the Qld Office of the Health Ombudsman.
Throughout her pharmacy career, Geraldine has held a strong interest in Pharmacovigilance and medication safety. During her doctoral research on Pharmacovigilance, she established and operated the NPS Adverse Medicine Events line, through which thousands of suspected adverse Drug reactions were reported by the general public and passed on to the TGA.
Dr. Mayada Alkhakany is a highly accomplished healthcare professional with an impressive track record of success in the pharmaceutical industry. Currently serving as Regional Healthcare Affair, Innovation, Patient Engagement Manager at Boehringer Ingelheim in the United Arab Emirates, she brings a wealth of experience to her role
Prior to her current position, Dr. Alkhakany held several other key positions at Boehringer Ingelheim, including Global Senior Non-Trial Activities Manager, where she led the review committee on a global level to approve non-trial projects. She also served as the head of pharmacovigilance in the Middle East, Turkey, and Africa, where she was responsible for ensuring patient safety across the region.
Before joining Boehringer Ingelheim, Dr. Alkhakany worked as an Associate Director of Pharmacovigilance at Merck Sharp & Dohme. She has also held various other positions with MSD, including Medical Advisor and Clinical Research Project Manager.
Dr. Alkhakany is a recognized leader in the field of pharmacovigilance and patient engagement. She is an Advisory board member of ISoP (International Society of Pharmacovigilance) for the 2023-2026 term and is the founder and chair of the ISoP Patient Engagement Group. She is also a co-founder and ex-president of the ISoP Middle East chapter and served as the chair of the local organizing committee for the annual meeting of ISoP in 2021. Additionally, Dr. Alkhakany is an active member of ISPOR (International Society for Pharmacoeconomics and Outcomes Research) in the patient engagement and digital solution groups.
Dr. Alkhakany holds a bachelor’s degree in Dentistry from Baghdad University in Iraq and has completed numerous international training programs in medical affairs, clinical research, business foundation, leadership, healthcare assessment tools, and coaching.
Throughout her career, Dr. Alkhakany has demonstrated a strong commitment to patient safety, innovation, and engagement. Her contributions to the pharmaceutical industry have been significant, and she is widely recognized as a leader in her field.
Dr. Manal Younus is currently the head of the Iraqi Pharmacovigilance Center based in MOH. Manal is a pharmacist with a Ph.D. in clinical pharmacy. She led the creation and expansion of the Iraqi pharmacovigilance system. Currently, she is an International Society of Pharmacovigilance (ISoP) fellow and ISoP Advisory Board member, working with students to increase awareness regarding pharmacovigilance. She is an Executive Committee member of the Council of International Organizations of Medical Sciences (CIOMS). Manal is the co-founder of the ISoP Patient Engagement SIG, the vice president of the ISoP Middle East chapter, and a member of both the ISoP Risk Minimization SIG and the ISoP Pharmacovigilance Professional Qualification Framework SIG. She had authored more than 40 articles on different drug safety-related subjects. She is a WHO bench-marking assessor. Finally, a member of the International Academy of Public Health’s (IAPH) Scientific Council and Antimicrobial Resistance Specialty Committee.
Prof. Rahman is in Pharmacology for more than 2 decades. He published 7 books, 17 chapters and more than 200 papers in various journals. He edited 11 periodicals and delivered/chaired more than 200 lectures as guest speaker and resource person. He attended 80 Workshops/Training Programs and presented papers during 90 International and 105 National Conferences. He organized 3 international conferences/CMEs and 22 national conferences/symposiums/CMEs and handled 7 academic projects. After MD (Pharmacology), he obtained PhD from Western Sydney University, Australia. With his initiative, PhD programme was started in the Department of Pharmacology, Aligarh.
He reported several ADRs and gave the concept of Environmental Pharmacovigilance. The term, ‘Pharmacoenvironmentology’ in relation to Environmental Pharmacovigilance was coined by him in 2006. He served the Society of Pharmacovigilance, India (SoPI) in various capacities. He started Journal of Pharmacovigilance & Drug Safety. Currently serving the Society as National Secretary. Indian Pharmacopoeia Commission nominated him as Coordinator of AMC-PvPI and MDMC-MvPI at JNMC, AMU, Aligarh. Being a member of ISoP, he takes interest in the Special Interest Group of Ecopharmacovigilance as well as Herbal and TM.
While working on morphine de-addiction properties, he proposed modified method for moderately and severely induced morphine dependent rats. He specifically screened Delphinium denudatum and Myristica fragrans for its protective activity in morphine induced physical dependence. Four of his MD candidates expanded the same work. He is the co-founder of Ibn Sina Academy of Medieval Medicine & Sciences for which he bequeathed his ancestral property worth millions of Indian Rupees. The Academy is designated as Centre of Excellence by Ministry of AYUSH, Govt. of India and listed in the Directory of History of Medicine, NLM, USA.
He received International Postgraduate Research Scholarship to pursue PhD from Australia. The same university decorated him with International Alumni Leadership Award. He was invited to serve as member jury panel to select Science Scholars Awards of Sun Pharma Science Foundation. He is member of 40 learned educational bodies including recipient of Fellowship of International Medical Sciences Academy (FIMSA), National Academy of Medical Sciences (MAMS/FAMS) and IMA Academy of Medical Specialities (FIAMS).
Jo Barnes is Professor in Herbal Medicines and Deputy Head of the School of Pharmacy in the Faculty for Medical and Health Sciences at the University of Auckland in New Zealand. Jo is the chapter lead for the Western Pacific chapter of the International Society of Pharmacovigilance, and was the founding chair of the Herbal and Traditional Medicines special interest of ISoP (2017-2022). Jo was a member of the Executive Committee of ISoP (2006-2009).
Dr Joanna Hikaka (Ngāruahine) is a pharmacist and Senior Research Fellow at the University of Auckland, New Zealand. Her clinical and research work focuses on older adult and Māori health, spanning primary, secondary, and aged residential care settings. Joanna is a Co-director of the newly established Centre for Co-Created Ageing Research at the University of Auckland and holds a number of regional and national governance and advisory roles relating to the responsible use of medicines, gerontology, and aged residential care. She is a Fulbright Scholar and previous winner of New Zealand Pharmacist of the Year (2019) and